Oral mucosal diseases: Erythema multiforme

被引:51
作者
Scully, Crispian [1 ]
Bagan, Jose [2 ]
机构
[1] UCL, Eastman Dent Inst, London WC1X 8LD, England
[2] Univ Gen Hosp, Serv Stomatol, Valencia, Spain
关键词
erythema multiforme; autoimmune; immunosuppressants; oral; vesiculobullous; skin;
D O I
10.1016/j.bjoms.2007.07.202
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Erythema multiforme (EM) is a rare acute mucocutaneous condition caused by a hypersensitivity reaction with the appearance of cytotoxic T lymphocytes in the epithelium that induce apoptosis in keratinocytes, which leads to satellite cell necrosis. EM can be triggered by a range of factors, but the best documented association is with preceding infection with herpes simplex virus (HSV). Most other cases are initiated by drugs. EM has been classified into a number of variants, mainly minor and major forms, as it may involve the mouth alone, or present as a skin eruption with or without oral or other lesions of the mucous membrane. EM minor typically affects only one mucosa, and may be associated with symmetrical target skin lesions on the extremities. EM major typically involves two or more mucous membranes with more variable skin involvement. A severe variant of EM major is Stevens-Johnson syndrome, which typically extensively involves the skin. Both EM major and Stevens-Johnson syndrome can involve internal organs and produce systemic symptoms. Treatment of EM is controversial, as there is no reliable evidence. Precipitants should be avoided or treated and, in severe cases, corticosteroids may be needed. Toxic epidermal necrolysis may be similar to Stevens-Johnson syndrome, but many experts regard it as a discrete disease, and therefore it is not discussed here. (C) 2007 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:90 / 95
页数:6
相关论文
共 36 条
[21]   Longitudinal study of a patient with herpes-simplex-virus-associated erythema multiforme: Viral gene expression and T cell repertoire usage [J].
Kokuba, H ;
Imafuku, S ;
Burnett, JW ;
Aurelian, L .
DERMATOLOGY, 1999, 198 (03) :233-242
[22]   RECURRENT AND CONTINUOUS ERYTHEMA MULTIFORME - A CLINICAL AND IMMUNOLOGICAL STUDY [J].
LEIGH, IM ;
MOWBRAY, JF ;
LEVENE, GM ;
SUTHERLAND, S .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1985, 10 (01) :58-67
[23]   Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature [J].
Letko, E ;
Papaliodis, DN ;
Papaliodis, GN ;
Daoud, YJ ;
Ahmed, AR ;
Foster, CS .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2005, 94 (04) :419-436
[24]   Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study [J].
Lin, MS ;
Dai, YS ;
Pwu, RF ;
Chen, YH ;
Chang, NC .
INTERNAL MEDICINE JOURNAL, 2005, 35 (03) :188-190
[25]  
MALMSTROM M, 1990, ACTA DERM-VENEREOL, V70, P405
[26]   DETECTION OF VIRAL-DNA WITHIN SKIN OF HEALED RECURRENT HERPES-SIMPLEX INFECTION AND ERYTHEMA MULTIFORME LESIONS [J].
MIURA, S ;
SMITH, CC ;
BURNETT, JW ;
AURELIAN, L .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (01) :68-72
[27]   MULTIPLE RECURRENCE OF ORAL ERYTHEMA MULTIFORME AFTER SECONDARY HERPES-SIMPLEX - REPORT OF CASE AND REVIEW OF LITERATURE [J].
NESBIT, SP ;
GOBETTI, JP .
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1986, 112 (03) :348-352
[28]   CD34+cells in the peripheral blood transport herpes simplex virus DNA fragments to the skin of patients with erythema multiforme (HAEM) [J].
Ono, F ;
Sharma, BK ;
Smith, CC ;
Burnett, JW ;
Aurelian, L .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (06) :1215-1224
[29]   Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis [J].
Paul, C ;
Wolkenstein, P ;
Adle, H ;
Wechsler, J ;
Garchon, HJ ;
Revuz, J ;
Roujeau, JC .
BRITISH JOURNAL OF DERMATOLOGY, 1996, 134 (04) :710-714
[30]   RECURRENT ERYTHEMA MULTIFORME - CLINICAL-FEATURES AND TREATMENT IN A LARGE SERIES OF PATIENTS [J].
SCHOFIELD, JK ;
TATNALL, FM ;
LEIGH, IM .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 128 (05) :542-545